18 June 2007 17:40 [Source: ICIS news]
(Adds closing share price in final paragraph)
By Nigel Davis
LONDON (ICIS news)--Counter bids for ICI were expected following Akzo Nobel’s offer of 600p a share or £7.2bn for the UK-based paints and specialty starch maker, financial analysts said on Monday.
An offer in excess of 630p per share would be required, Jeremy Batstone of stockbrokers Charles Stanley said in a note to clients.
ICI could ultimately fall to an offer of as much as 700p a share, he added, given the possibility of a bid battle developing between Akzo and Dow Chemical or other interested parties, including BASF and Reliance.
ICI on Monday rejected Akzo Nobel’s offer.
Akzo said ICI would represent a highly attractive addition to its focused coatings and chemicals business following the announced sale of pharmaceuticals arm Organon BioSciences to Schering-Plough earlier this year for €11bn.
It was unclear, however, whether the company would respond to ICI's rejection with a higher bid.
“Akzo Nobel will continue to evaluate all strategic opportunities, including ICI, based on a disciplined and value-driven approach to earnings and returns over cost of capital,” the company added in a statement.
Chemicals analyst Charles Bailey, of Brewin Dolphin, said he fully expected Akzo Nobel to come in with a counter bid.
“All the synergies make sense,” Bailey said. “Akzo have €15bn in the bank and ICI are a restructured company with good geographic exposure and impressive brands in the coatings industry.”
Bailey said a bidding war could drive the price up to 700-750 pence per share.
A successful bid from Akzo Nobel might be expected to prompt an anti-trust investigation in the
The European coatings market, however, appears sufficiently fragmented to suggest only limited anti-trust issues, he said.
ICI's shares closed at 634.5 pence, up just over 15% on Friday's close. They hit a high of 644 pence earlier on Monday.
($1 = €0.75/£0.51)
Mark Watts contributed to this article
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|
|
ICIS Chemicals Confidential